At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Myocardial Function, Free Fatty Acid and Glucose Metabolism in HIV Metabolic Syndrome
In Brief
A clinical study evaluating Pioglitazone and Exercise Training for HIV Infections and 4 related conditions. Completed, enrolled 24 participants across 1 site.
Detailed Summary
We hypothesize that the hearts of HIV+ people with The Metabolic Syndrome use and oxidize fats and sugars inappropriately, and that this may impair the heart's ability to pump blood. We hypothesize that exercise training or pioglitazone (Actos) will improve fat and sugar metabolism in the hearts of HIV+ people with The Metabolic Syndrome. This study will advance our understanding of cardiovascular disease in HIV+ people, and will test the efficacy of exercise training and pioglitazone for improving insulin resistance, heart metabolism and heart function in this at risk population.
Study Details
Timeline
Interventions
30mg/day for 16 weeks
Cardiorespiratory and resistance exercise training 3days/wk for 16 weeks